XPEV - Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire China Targets Stock Market Revival FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories | Benzinga

August, 28 2023 02:37 PM XPeng Inc. American depositary shares each representing two Class A

Reuters

Walmart Inc (NYSE: WMT) has reportedly resolved the University of California's light-bulb patent lawsuit.
The university accused the retail behemoth of infringing its patents associated with "filament" LED light bulbs (invented at the Santa Barbara-based school system).
The federal judge in Los Angeles would dismiss the case with prejudice, which means it cannot be refiled.

Renault SA (OTC: RNLSY) (OTC: RNSDF) is reportedly expecting to list its electric vehicle business unit, Ampere, on the stock market in the spring of 2024.
Renault Chief Executive Officer Luca de Meo said the automaker was targeting November 1 of this year for Ampere to be separated from the rest of the company.
"So we separate, and then we see if we have the right conditions to enter the market," said Luca de Meo.

Swiss investment bank Credit Suisse, currently a subsidiary of UBS Inc (NYSE: UBS), reportedly posted a loss of $4 billion for the second quarter, in line with the forecast issued in April.
Credit Suisse's second-quarter loss amounted to 3.5 billion Swiss francs.
Credit Suisse had previously forecast a significant pre-tax loss for the second quarter and for all of 2023, given its move to exit from non-core businesses and restructuring and financing costs.

Wall Street Journal

The Supreme Court is set to examine Purdue Pharma's proposed restructuring, the opioid company that sought bankruptcy in 2019. This move may change a four-decade method for managing vast legal liabilities from large-scale lawsuits.
The tactic dates back to Johns Manville, a prominent asbestos firm that declared bankruptcy in 1982 due to myriad lawsuits. Despite bankruptcy laws permitting restructuring of present claims, many claimants wouldn't fall ill until years post-bankruptcy.

The Federal Trade Commission decided to momentarily halt its challenge against pharmaceutical giant Amgen, Inc (NASDAQ: AMGN), concerning its proposed acquisition of Horizon Therapeutics PLC (NASDAQ: HZNP) valued at $27.8 billion.
The move presents a window of opportunity to contemplate a potential settlement, which might allow the deal to move forward under specific conditions.
In a document submitted to the court last week, the FTC revealed its intention to suspend the challenge it ...

Company Name:	XPeng Inc. American depositary shares each representing two Class A
Stock Symbol:	XPEV
Market:	NYSE